FDA Says Existing Applications for Obesity Drugs Unlikely to Be Affected by Panel Findings (VVUS) (ARNA) (OREX)

Go back to FDA Says Existing Applications for Obesity Drugs Unlikely to Be Affected by Panel Findings (VVUS) (ARNA) (OREX)